EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020)

Leah Burn, Thao Mai Phuong Tran, Andreas Pilz, Andrew Vyse, Mark A Fletcher, Frederick J Angulo, Bradford D Gessner, Jennifer C Moïsi, Luis Jodar, James H Stark

Vector-Borne and Zoonotic Diseases · 2023-04 · 23 (4) · 156-171

DOI: 10.1089/vbz.2022.0071 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Vector-Borne and Zoonotic Diseases, online erschienen am 12.04.2023. Verfasst von Leah Burn und 9 weiteren Autor:innen. Beteiligte Einrichtung: P95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Lyme Disease, Tick-Borne Diseases. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lyme borreliosis (LB) is the most common tick-borne disease in Europe. To inform European intervention strategies, including vaccines under development, we conducted a systematic review for LB incidence.

Methods

We searched publicly available surveillance data reporting LB incidence in Europe from 2005 to 2020. Population-based incidence was calculated as the number of reported LB cases per 100,000 population per year (PPY), and high LB risk areas (incidence >10/100,00 PPY for 3 consecutive years) were estimated.

Results

Estimates of LB incidence were available for 25 countries. There was marked heterogeneity in surveillance systems (passive vs. mandatory and sentinel sites vs. national), case definitions (clinical, laboratory, or both), and testing methods, limiting comparison across countries. Twenty-one countries (84%) had passive surveillance; four (Belgium, France, Germany, and Switzerland) used sentinel surveillance systems. Only four countries (Bulgaria, France, Poland, and Romania) used standardized case definitions recommended by European public health institutions. Among all surveillance systems and considering any case definition for the most recently available years, national LB incidences were highest in Estonia, Lithuania, Slovenia, and Switzerland (>100 cases/100,000 PPY), followed by France and Poland (40–80/100,000 PPY), and Finland and Latvia (20–40/100,000 PPY). Incidences were lowest in Belgium, Bulgaria, Croatia, England, Hungary, Ireland, Norway, Portugal, Romania, Russia, Scotland, and Serbia (100/100,000 PPY) were observed in areas of Belgium, Czech Republic, France, Germany, and Poland. Overall, on average 128,888 cases are reported annually. An estimated 202/844 million (24%) persons in Europe reside in areas of high LB incidence and 202/469 million (43.2%) persons reside in areas of high LB incidence among countries with surveillance data.

Conclusion

Our review showed substantial variability in reported LB incidence across and within European countries, with highest incidences reported from the Eastern, Northern (Baltic states and Nordic countries), and Western Europe surveillance systems. Standardization of surveillance systems, including wider implementation of common case definitions, is urgently needed to interpret the range of differences in LB incidence observed across European countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseTick-Borne DiseasesAnimalsIncidenceEuropePoland

Stichwörter der Autor:innen

EuropeLyme borreliosisepidemiologyincidencesurveillance

Autor:innen und Institutionen

  • P95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA.
  • P95 Pharmacovigilance & Epidemiology, Leuven, Belgium.
  • Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.
  • Pfizer Vaccines Medical, Walton Oaks, Surrey, United Kingdom.
  • Pfizer Emerging Markets Medical Affairs, Vaccines, Paris, France.
  • Pfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.

Zitieren

APA

Burn, L., Tran, T. M. P., Pilz, A., Vyse, A., Fletcher, M. A., Angulo, F. J., Gessner, B. D., Moïsi, J. C., Jodar, L., & Stark, J. H. (2023). Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020). Vector-Borne and Zoonotic Diseases, 23(4), 156-171. https://doi.org/10.1089/vbz.2022.0071

Vancouver

Burn L, Tran TMP, Pilz A, Vyse A, Fletcher MA, Angulo FJ, et al. Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020). Vector-Borne and Zoonotic Diseases. 2023;23(4):156-171. doi:10.1089/vbz.2022.0071

BibTeX
@article{Burn2023,
  author = {Burn, Leah and Tran, Thao Mai Phuong and Pilz, Andreas and Vyse, Andrew and Fletcher, Mark A and Angulo, Frederick J and Gessner, Bradford D and Moïsi, Jennifer C and Jodar, Luis and Stark, James H},
  title = {Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020)},
  journal = {Vector-Borne and Zoonotic Diseases},
  year = {2023},
  volume = {23},
  number = {4},
  pages = {156--171},
  doi = {10.1089/vbz.2022.0071}
}
Kostenlos starten →